Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 9,373-9,384 of 10,592
Other study type icon
Active Not RecruitingNCT06002204

Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression

This observational study is following people with Depression, Treatment Resistant Depression, bipolarity, or Mental Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Depression, BipolarityOtherOver 10 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT04010305

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT02548559

Sublingual Cannabidiol for Anxiety

This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

In United States
AnxietyDrugOver 18 Years
Countries
United States
Sponsor
Staci Gruber, Ph.D.
Condition
Anxiety
Drug study icon
Active Not RecruitingNCT05712707

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Other study type icon
CompletedNCT05860959

SUBLOCADE Long-term Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionOtherOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Indivior Inc.
Condition
Addiction
Behavioral study icon
CompletedNCT04060654

SUBLOCADE Rapid Initiation Extension Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Indivior Inc.
Condition
Addiction
Device study icon
WithdrawnNCT05790551

Suboxone Dispenser for OUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
Addinex Technologies, Inc.
Condition
Addiction
Behavioral study icon
CompletedNCT01413984

Substance Abuse and Trauma in Incarcerated Women

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralOver 18 Years
Countries
United States
Sponsor
University of Tulsa
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.